France CINV Existing and Pipeline Drugs Market (2025-2031) | Industry, Share, Trends, Segmentation, Growth, Size & Revenue, Companies, Outlook, Forecast, Competitive Landscape, Analysis, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 France Country Macro Economic Indicators

3.2 France CINV Existing and Pipeline Drugs Market Revenues & Volume, 2021 & 2031F

3.3 France CINV Existing and Pipeline Drugs Market - Industry Life Cycle

3.4 France CINV Existing and Pipeline Drugs Market - Porter's Five Forces

3.5 France CINV Existing and Pipeline Drugs Market Revenues & Volume Share, By Major Drug, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) in France

4.2.2 Growing adoption of innovative treatment options for CINV

4.2.3 Rising healthcare expenditure and government initiatives to improve cancer care in France

4.3 Market Restraints

4.3.1 Stringent regulations and lengthy approval processes for new drugs in the market

4.3.2 High costs associated with CINV drugs and treatments

4.3.3 Competition from alternative therapies and non-pharmacological interventions for CINV management

6.1 France CINV Existing and Pipeline Drugs Market, By Major Drug

6.1.1 Overview and Analysis

6.1.2 France CINV Existing and Pipeline Drugs Market Revenues & Volume, By Major Drug, 2021- 2031F

6.1.3 France CINV Existing and Pipeline Drugs Market Revenues & Volume, By Aloxi (Palonosetron), 2021- 2031F

6.1.4 France CINV Existing and Pipeline Drugs Market Revenues & Volume, By Zofran Generic (Ondansetron), 2021- 2031F

6.1.5 France CINV Existing and Pipeline Drugs Market Revenues & Volume, By Kytril Generic (Granisetron), 2021- 2031F

6.1.6 France CINV Existing and Pipeline Drugs Market Revenues & Volume, By Emend (Aprepitant), 2021- 2031F

6.1.7 France CINV Existing and Pipeline Drugs Market Revenues & Volume, By Akynzeo (Netupitant-Palonosetron), 2021- 2031F

6.1.8 France CINV Existing and Pipeline Drugs Market Revenues & Volume, By SUSTOL (Extended Release Granisetron Injection), 2021- 2031F

7.1 France CINV Existing and Pipeline Drugs Market Export to Major Countries

7.2 France CINV Existing and Pipeline Drugs Market Imports from Major Countries

8.1 Patient adherence rates to CINV treatment regimens

8.2 Number of clinical trials for novel CINV drugs in France

8.3 Rate of adoption of guidelines for CINV management by healthcare providers

9.1 France CINV Existing and Pipeline Drugs Market Opportunity Assessment, By Major Drug, 2021 & 2031F

10.1 France CINV Existing and Pipeline Drugs Market Revenue Share, By Companies, 2024

10.2 France CINV Existing and Pipeline Drugs Market Competitive Benchmarking, By Operating and Technical Parameters